Société PAREXEL International Corporation
Actions
US6994621075
Recherche biotechnologique et médicale
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Duncan MacDonald
CEO | Chief Executive Officer | 56 | - |
Gregory Rush
DFI | Director of Finance/CFO | 56 | - |
Amy McKee
CTO | Chief Tech/Sci/R&D Officer | 52 | 01/01/19 |
Michael Crowley
ADM | Chief Administrative Officer | - | 01/01/09 |
Jonathan Shough
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/22 |
Peyton Howell
COO | Chief Operating Officer | 56 | 01/05/18 |
Investor Relations Contact | - | - | |
Corporate Officer/Principal | - | 01/01/20 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Sherilyn McCoy
CHM | Chairman | 65 | - |
Duncan MacDonald
CEO | Chief Executive Officer | 56 | - |
May Kin Ho
BRD | Director/Board Member | 71 | 26/08/15 |
Eric Liu
BRD | Director/Board Member | 47 | 01/11/21 |
William Chase
BRD | Director/Board Member | 57 | - |
John Groetelaars
BRD | Director/Board Member | 58 | 23/06/23 |
Michael Bruun
BRD | Director/Board Member | - | 23/06/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 51 115 310 | 50 131 867 ( 98,08 %) | 0 | 98,08 % |
Coordonnées société
PAREXEL International Corp.
275 Grove Street Suite 101C
02466, Newton
+617 454 9300
http://www.parexel.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+1,51 % | 42,75 Md | |
+48,32 % | 41,61 Md | |
+8,57 % | 41,34 Md | |
-12,36 % | 26,59 Md | |
+8,92 % | 25,49 Md | |
-25,13 % | 18,12 Md | |
+29,17 % | 12,24 Md | |
-3,12 % | 11,76 Md | |
+6,35 % | 11 Md |